Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
52708-36-8
Purity
95%
4-Benzimidazol-1-yl-aniline shows inhibitory activity against platelet-derived growth factor-activated receptor.
Properties
Name
4-Benzimidazol-1-ylaniline
Smiles
NC=1C=CC(=CC1)N2C=NC=3C=CC=CC23
Targets
Please log in to see this information
1-(4-aminophenyl)benzimidazol | 1-p-aminophenylbenzimidazole | 4-(1H-benzimidazol-1-yl)aniline | 4-benzoimidazol-1-yl-aniline | N-(4-aminophenyl)benzimidazole
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$82
2 mg
$84
5 mg
$89
10 mg
$115
15 mg
$156
20 mg
$195
25 mg
$214
30 mg
$236
35 mg
$255
40 mg
$276
45 mg
$297
50 mg
$336
75 mg
$502
100 mg
$POA
Quantity
1
Total amount
$ 89
1-(4-aminophenyl)benzimidazol | 1-p-aminophenylbenzimidazole | 4-(1H-benzimidazol-1-yl)aniline | 4-benzoimidazol-1-yl-aniline | N-(4-aminophenyl)benzimidazole
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.